Hypertension is the most common modifiable risk factor for cardiovascular disease and death, and lowering blood pressure with antihypertensive drugs reduces target organ damage and prevents cardiovascular disease outcomes.

Most hypertensive patients will need a combination of antihypertensive agents to achieve the therapeutic goals. Recent guidelines recommend initiating treatment with two drugs in those patients with a systolic blood pressure >20 mmHg and/or a diastolic blood pressure >10 mmHg above the goals, and in those patients with high cardiovascular risk. In addition, approximately 25% of patients will require three antihypertensive agents to achieve the therapeutic targets.

Related Articles


The Role of Oral Vasoactive Agents in the Treatment of Pulmonary Arterial…

Omar A Minai,

Citation: US Cardiology 2006;3(1):1–5

Renal Denervation After Symplicity HTN-3 – Back to Basics. Review of the…

Alexandre Persu, Fadl Elmula M Fadl Elmula, Yu Jin,

Citation: European Cardiology Review 2014;9(2):110–4

Hypertension in Chronic Kidney Disease

Olivier Phan, Michel Burnier, Grégoire Wuerzner,

Citation: European Cardiology Review 2014;9(2):115–20

Outpatient Evaluation of Secondary Causes of Resistant Hypertension

George Thomas, Emmanuel L Bravo,

Citation: European Cardiology 2011;7(4):264–9